Attovia Therapeutics Inc.
ATTO | NASDAQ
$21.30
-$0.84 (-3.79%)
At close: Sep 21, 2026, 4:00 PM ET
Market Data
Market Cap $952.68M
Enterprise Value $805.73M
Beta 0.00
Average Volume 463.67K
Shares Outstanding (Diluted) 45.65M
Shares Change YoY N/A
Institutional Ownership N/A
Exchange NASDAQ
ISIN US04987L1026
Price Performance
Price Change 1M 5.4%
Price Change 3M -2.7%
Price Change 6M -2.7%
Price Change YTD -2.7%
Price Change 1Y -2.7%
Price Change 3Y 5.6%
Price Change 5Y 5.6%
1M CAGR (ann.) 8.6%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR 9.5%
Valuation
PE Ratio -22.90
Forward PE N/A
PEG Ratio 0.29
Forward PEG 0.58
PS Ratio 2,036.75
Forward PS 678.90
PB Ratio 8.13
P/FCF Ratio -25.97
P/Adj. FCF Ratio -25.97
P/OCF Ratio -27.66
EV/Sales 1,790.52
EV/EBIT -19.30
EV/EBITDA -19.52
EV/FCF -22.83
Earnings Yield -4.4%
FCF Yield -3.9%
Adj. FCF Yield -3.9%
Financial Health
Net Cash $113.09M
Total Debt $4.33M
Cash & Short-Term Investments $115.13M
Total Assets $128.35M
Current Ratio 9.39
Quick Ratio 9.39
Debt / Equity Ratio 0.04
Debt / EBITDA -0.10
Debt / FCF -0.12
OCF / Debt -8.07
Interest Coverage 0.00
Altman Z-Score 34.97
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin -8.4%
Operating Profit Margin -9279.6%
EBITDA Margin -9171.1%
Net Profit Margin -8742.9%
FCF Margin -7842.9%
Adj. FCF Margin -7842.9%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets -30.6%
Return on Equity -32.0%
Return on Invested Capital -35.5%
Return on Capital Employed -36.1%
Return on Tangible Assets -30.6%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Sep 1, 2026
EPS Estimate (next Q) -$0.65
EPS Growth Est (next Q) N/A
Revenue Est (next Q) $316.67K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $45.33
Price Target Upside 112.8%
Cash Flow
Operating Cash Flow $-34.93M
Free Cash Flow $-35.29M
Adj. Free Cash Flow $-35.29M
FCF Per Share -$0.77
OCF Per Share -$0.77
OCF/S Ratio -7762.7%
Income Statement
Revenue $450K
Gross Profit $-38K
Operating Income $-41.76M
EBITDA $-41.27M
Net Income $-39.34M
EPS (Diluted) -$0.93
Revenue / Employee $10.23K
Profit / Employee $-894.16K
Employees 44
Add to Watchlist
Select watchlists to add or remove ATTO